Translational Research
Volume 156, Issue 3 , Pages 161-168 , September 2010

Stem cell technology for the treatment of acute and chronic renal failure

  • Christopher J. Pino

      Affiliations

    • Innovative BioTherapies, Inc, University of Michigan Medical School, Ann Arbor, Mich
    • ,
  • H. David Humes

      Affiliations

    • Innovative BioTherapies, Inc, University of Michigan Medical School, Ann Arbor, Mich
    • Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Mich
    • Corresponding Author InformationReprint requests: H. David Humes, MD, Innovative BioTherapies, Inc., 401 W. Morgan Rd., Ann Arbor, MI 48108

References 

  1. United States Renal Data System. USRDS 2009 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2009;
  2. Nigam S, Lieberthal W. Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Renal Physiol. 2000;279:F3–F11
  3. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334:1448–1460
  4. Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol. 2000;278:F1–F12
  5. Lieberthal W, Nigam SK. Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol. 1998;275:F623–F631
  6. Breen D, Bihari D. Acute renal failure as a part of multiple organ failure: the slippery slope of critical illness. Kidney Int Suppl. 1998;66:S25–S33
  7. Humes HD. Cell therapy: leveraging nature’s therapeutic potential. J Am Soc Nephrol. 2003;14:2211–2213
  8. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem Cells. 2004;22:487–500
  9. Alison MR, Poulsom R, Forbes S, Wright NA. An introduction to stem cells. J Pathol. 2002;197:419–423
  10. Rosenthal N. Prometheus’s vulture and the stem-cell promise. N Engl J Med. 2003;349:267–274
  11. Rippon HJ, Bishop AE. Embryonic stem cells. Cell Prolif. 2004;37:23–34
  12. Drazen JM. Legislative myopia on stem cells. N Engl J Med. 2003;349:300
  13. Daley GQ. Cloning and stem cells—handicapping the political and scientific debates. N Engl J Med. 2003;349:211–212
  14. de Wert G, Mummery C. Human embryonic stem cells: research, ethics and policy. Hum Reprod. 2003;18:672–682
  15. Phimister EG, Drazen JM. Two fillips for human embryonic stem cells. N Engl J Med. 2004;350:1351–1352
  16. Saxen L. Organogenesis of the kidney. Cambridge, UK: Cambridge University Press; 1987;
  17. Al-Awqati Q, Oliver JA. Stem cells in the kidney. Kidney Int. 2002;61:387–395
  18. Herzlinger D, Koseki C, Mikawa T, al-Awqati Q. Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction. Development. 1992;114:565–572
  19. Oliver JA, Barasch J, Yang J, Herzlinger D, Al-Awqati Q. Metanephric mesenchyme contains embryonic renal stem cells. Am J Physiol Renal Physiol. 2002;283:F799–F809
  20. Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J Clin Invest. 2004;114:795–804
  21. Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol. 2006;17:2443–2456
  22. Humphreys BD, Bonventre JV. The contribution of adult stem cells to renal repair. Nephrol Ther. 2007;3:3–10
  23. Bussolati B, Camussi G. Stem cells in acute kidney injury. Contrib Nephrol. 2007;156:250–258
  24. Romagnani P. Toward the identification of a “renopoietic system”?. Stem Cells. 2009;27:2247–2253
  25. Little MH, Bertram JF. Is there such a thing as a renal stem cell?. J Am Soc Nephrol. 2009;20:2112–2117
  26. Safirstein R. Renal regeneration: reiterating a developmental paradigm. Kidney Int. 1999;56:1599–1600
  27. Nony PA, Schnellmann RG. Mechanisms of renal cell repair and regeneration after acute renal failure. J Pharmacol Exp Ther. 2003;304:905–912
  28. Forbes SJ, Vig P, Poulsom R, Wright NA, Alison MR. Adult stem cell plasticity: new pathways of tissue regeneration become visible. Clin Sci (Lond). 2002;103:355–369
  29. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries?. Nat Med. 2001;7:393–395
  30. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001;17:387–403
  31. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41–49
  32. Ratajczak MZ, Kucia M, Majka M, Reca R, Ratajczak J. Heterogeneous populations of bone marrow stem cells—are we spotting on the same cells from the different angles?. Folia Histochem Cytobiol. 2004;42:139–146
  33. Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 2003;112:42–49
  34. Szczypka MS, Westover AJ, Clouthier SG, Ferrara JL, Humes HD. Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury. Stem Cells. 2005;23:44–54
  35. Gupta S, Verfaillie C, Chmielewski D, Kim Y, Rosenberg ME. A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int. 2002;62:1285–1290
  36. Lange C, Tögel F, Ittrich H, et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005;68:1613–1617
  37. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005;289:F31–F42
  38. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007;292:F1626–F1635
  39. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views. Stem Cells. 2007;25:2896–2902
  40. Bruno S, Grange C, Deregibus MC, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009;20:1053–1067
  41. Camussi G, Deregibus MC, Tetta C. Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens. 2010;19:7–12
  42. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007;211:27–35
  43. Togel FE, Westenfelder C. Mesenchymal stem cells: a new therapeutic tool for AKI. Nat Rev Nephrol. 2010;6:179–183
  44. Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant. 2008;14:631–640
  45. Zhou H, Tian HM, Long Y, et al. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats. Chin Med J (Engl). 2009;122:2573–2579
  46. Goligorsky MS, Kuo MC, Patschan D, Verhaar MC. Review article: endothelial progenitor cells in renal disease. Nephrology (Carlton). 2009;14:291–297
  47. Steenhard BM, Isom KS, Cazcarro P. Integration of embryonic stem cells in metanephric kidney organ culture. J Am Soc Nephrol. 2005;16:1623–1631
  48. Kobayashi T, Tanaka H, Kuwana H, et al. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun. 2005;336:585–595
  49. Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol. 2005;16:3527–3534
  50. Morizane R, Monkawa T, Itoh H. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro. Biochem Biophys Res Commun. 2009;390:1334–1339
  51. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676
  52. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–317
  53. Esteban MA, Wang T, Qin B, et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell. 2010;6:71–79
  54. Feng Q, Lu SJ, Klimanskaya I, et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells. 2010;28:704–712
  55. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009;4:472–476
  56. Yokoo T, Kawamura T, Kobayashi E. Kidney organogenesis and regeneration: a new era in the treatment of chronic renal failure?. Clin Exp Nephrol. 2008;12:326–331
  57. Hammerman MR. Growing new kidneys in situ. Clin Exp Nephrol. 2004;8:169–177
  58. Woolf AS, Palmer SJ, Snow ML, Fine LG. Creation of a functioning chimeric mammalian kidney. Kidney Int. 1990;38:991–997
  59. Rogers SA, Lowell JA, Hammerman NA, Hammerman MR. Transplantation of developing metanephroi into adult rats. Kidney Int. 1998;54:27–37
  60. Hammerman MR. Tissue engineering the kidney. Kidney Int. 2003;63:1195–1204
  61. Saito A, Kazama JJ, Iino N, et al. Bioengineered implantation of megalin-expressing cells: a potential intracorporeal therapeutic model for uremic toxin protein clearance in renal failure. J Am Soc Nephrol. 2003;14:2025–2032
  62. Orive G, Hernández RM, Rodríguez Gascón A, et al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 2004;22:87–92
  63. Chang TM, Prakash S. Therapeutic uses of microencapsulated genetically engineered cells. Mol Med Today. 1998;4:221–227
  64. Goldberg MA, Glass GA, Cunningham JM, Bunn HF. The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci U S A. 1987;84:7972–7976
  65. Humes HD. Implantable device and use thereof. Ann Arbor, MI: Nephros Therapeutics, Inc.; 1998;
  66. Humes HD. Bioartificial kidney for full renal replacement therapy. Semin Nephrol. 2000;20:71–82
  67. Amiel GE, Yoo JJ, Atala A. Renal therapy using tissue-engineered constructs and gene delivery. World J Urol. 2000;18:71–79
  68. Lanza RP, Chung HY, Yoo JJ, et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol. 2002;20:689–696
  69. Koh CJ, Atala A. Therapeutic cloning applications for organ transplantation. Transpl Immunol. 2004;12:193–201
  70. Hochedlinger K, Jaenisch R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature. 2002;415:1035–1038
  71. Meissner A, Jaenisch R. Mammalian nuclear transfer. Dev Dyn. 2006;235:2460–2469
  72. Humes HD, Cieslinski DA. Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp Cell Res. 1992;201:8–15
  73. Humes HD, Krauss JC, Cieslinski DA, Funke AJ. Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus. Am J Physiol. 1996;271:F42–F49
  74. MacKay SM, Funke AJ, Buffington DA, Humes HD. Tissue engineering of a bioartificial renal tubule. ASAIO J. 1998;44:179–183
  75. Humes HD, MacKay SM, Funke AJ, Buffington DA. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int. 1999;55:2502–2514
  76. Nikolovski J, Gulari E, Humes HD. Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant. 1999;8:351–364
  77. Tiranathanagul K, Eiam-Ong S, Humes HD. The future of renal support: high-flux dialysis to bioartificial kidneys. Crit Care Clin. 2005;21:379–394
  78. Humes HD, Fissell WH, Weitzel WF. The bioartificial kidney in the treatment of acute renal failure. Kidney Int Suppl. 2002;121–125
  79. Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol. 1999;17:451–455
  80. Humes HD, Fissell WH, Weitzel WF, et al. Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am J Kidney Dis. 2002;39:1078–1087
  81. Humes HD, Buffington DA, Lou L, et al. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Crit Care Med. 2003;31:2421–2428
  82. Humes HD, Weitzel WF, Bartlett RH, et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 2004;66:1578–1588
  83. Tumlin J, Wali R, Williams W, et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol. 2008;19:1034–1040
  84. Fahy GM, Wowk B, Wu J. Cryopreservation of complex systems: the missing link in the regenerative medicine supply chain. Rejuvenation Res. 2006;9:279–291
  85. Westover A, Buffington H, Humes HD. Enhanced propagation of adult human renal epithelial cells. Washington, DC: American Society of Nephrology; 2009;
  86. Buffington D, Hageman G, Wang M, et al. Design of a compact cryopreservable bioartificial renal cell system. Washington, DC: American Society of Nephrology; 2009;
  87. Rojas A, Hageman G, Lou L, et al. Animal model of a wearable bioartificial kidney using peritoneal dialysis. ASAIO 2009 Annual Meeting; Baltimore, MD, 2009.
  88. Song J, Jung J, Ding F, et al. Uremic animal model of bioartifical renal cell system (BRECS) using continuous flow peritoneal dialysis-based extracorporeal circuit. Washington, DC: American Society of Nephrology; 2009;
  89. Gerecht-Nir S, Itskovitz-Eldor J. Human embryonic stem cells: a potential source for cellular therapy. Am J Transplant. 2004;4:51–57
  90. Drukker M, Benvenisty N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 2004;22:136–141

PII: S1931-5244(10)00153-2

doi: 10.1016/j.trsl.2010.07.005

Translational Research
Volume 156, Issue 3 , Pages 161-168 , September 2010

Article Tools